Related Experiment Videos
Current trends and future directions in the genetic therapy of human neoplastic disease
Abstract:
All of these initiatives are exciting and may provide therapy that is not as destructive to normal tissues as most existing modalities of therapy, because the therapy is directed to particular molecular defects in the tumor cells. Possibly, this therapy can be individualized for the defects present within the cancer cell that result in disease. Such therapy could reduce treatment costs, because it will be less toxic and, therefore, more cost-effective. We are making the transition to therapy directed to molecular targets and specific for each patient. The potential rewards of this new direction are great in terms of improvement of the therapeutic outcome and reduction of toxicity and cost. Let us hope that the systematic study of these principles of therapy, which is now underway in many medical centers, will alter the unfavorable natural history that characterizes many of the most commonly encountered neoplastic diseases in humans.
Insights
New cancer therapies target specific molecular defects in tumor cells, offering less destructive and more cost-effective treatment options. This personalized approach promises improved outcomes and reduced toxicity for patients with neoplastic diseases.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Current cancer therapies often cause significant damage to normal tissues.
- There is a need for more targeted and less toxic treatment modalities.
Discussion:
- Emerging therapies focus on specific molecular defects within cancer cells.
- This targeted approach allows for personalized treatment strategies tailored to individual patients.
- Such individualized therapy has the potential to be less toxic and more cost-effective than conventional treatments.
Key Insights:
- Molecularly targeted cancer therapy offers a paradigm shift in treatment.
- Personalized medicine in oncology aims to improve therapeutic outcomes.
- Reduced toxicity and cost are significant potential benefits of these new approaches.
Outlook:
- Systematic study of these principles is underway in multiple medical centers.
- This research holds the promise of altering the natural history of common human neoplastic diseases.
- The transition to targeted molecular therapies is expected to yield substantial improvements in cancer care.